BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Goh WJ, Zou S, Lee CK, Ou Y, Wang J, Czarny B, Pastorin G. EXOPLEXs: Chimeric Drug Delivery Platform from the Fusion of Cell-Derived Nanovesicles and Liposomes. Biomacromolecules 2018;19:22-30. [DOI: 10.1021/acs.biomac.7b01176] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
Number Citing Articles
1 Weng Z, Zhang B, Wu C, Yu F, Han B, Li B, Li L. Therapeutic roles of mesenchymal stem cell-derived extracellular vesicles in cancer. J Hematol Oncol 2021;14:136. [PMID: 34479611 DOI: 10.1186/s13045-021-01141-y] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Vakhshiteh F, Atyabi F, Ostad SN. Mesenchymal stem cell exosomes: a two-edged sword in cancer therapy. Int J Nanomedicine 2019;14:2847-59. [PMID: 31114198 DOI: 10.2147/IJN.S200036] [Cited by in Crossref: 72] [Cited by in F6Publishing: 50] [Article Influence: 24.0] [Reference Citation Analysis]
3 Shin MJ, Park JY, Lee DH, Khang D. Stem Cell Mimicking Nanoencapsulation for Targeting Arthritis. Int J Nanomedicine 2021;16:8485-507. [PMID: 35002240 DOI: 10.2147/IJN.S334298] [Reference Citation Analysis]
4 Biasutto L, Mattarei A, La Spina M, Azzolini M, Parrasia S, Szabò I, Zoratti M. Strategies to target bioactive molecules to subcellular compartments. Focus on natural compounds. Eur J Med Chem 2019;181:111557. [PMID: 31374419 DOI: 10.1016/j.ejmech.2019.07.060] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
5 Vembadi A, Menachery A, Qasaimeh MA. Cell Cytometry: Review and Perspective on Biotechnological Advances. Front Bioeng Biotechnol 2019;7:147. [PMID: 31275933 DOI: 10.3389/fbioe.2019.00147] [Cited by in Crossref: 40] [Cited by in F6Publishing: 32] [Article Influence: 13.3] [Reference Citation Analysis]
6 Ma G, Severic M, Barker M, Pereira S, Ruiz A, Cheung CCL, Al-Jamal WT. Dually targeted bioinspired nanovesicle delays advanced prostate cancer tumour growth in vivo. Acta Biomater 2021:S1742-7061(21)00452-9. [PMID: 34274531 DOI: 10.1016/j.actbio.2021.07.021] [Reference Citation Analysis]
7 Li Y, Zhang Y, Li Z, Zhou K, Feng N. Exosomes as Carriers for Antitumor Therapy. ACS Biomater Sci Eng 2019;5:4870-81. [PMID: 33455237 DOI: 10.1021/acsbiomaterials.9b00417] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
8 Evers MJW, van de Wakker SI, de Groot EM, de Jong OG, Gitz-François JJJ, Seinen CS, Sluijter JPG, Schiffelers RM, Vader P. Functional siRNA Delivery by Extracellular Vesicle-Liposome Hybrid Nanoparticles. Adv Healthc Mater 2021;:e2101202. [PMID: 34382360 DOI: 10.1002/adhm.202101202] [Reference Citation Analysis]
9 Hu M, Zhang J, Kong L, Yu Y, Hu Q, Yang T, Wang Y, Tu K, Qiao Q, Qin X, Zhang Z. Immunogenic Hybrid Nanovesicles of Liposomes and Tumor-Derived Nanovesicles for Cancer Immunochemotherapy. ACS Nano 2021;15:3123-38. [PMID: 33470095 DOI: 10.1021/acsnano.0c09681] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
10 Thanuja M Y, Anupama C, Ranganath SH. Bioengineered cellular and cell membrane-derived vehicles for actively targeted drug delivery: So near and yet so far. Adv Drug Deliv Rev 2018;132:57-80. [PMID: 29935987 DOI: 10.1016/j.addr.2018.06.012] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 9.0] [Reference Citation Analysis]
11 Ou YH, Zou S, Goh WJ, Wang JW, Wacker M, Czarny B, Pastorin G. Cell-Derived Nanovesicles as Exosome-Mimetics for Drug Delivery Purposes: Uses and Recommendations. Methods Mol Biol 2021;2211:147-70. [PMID: 33336276 DOI: 10.1007/978-1-0716-0943-9_11] [Reference Citation Analysis]
12 Chong SY, Lee CK, Huang C, Ou YH, Charles CJ, Richards AM, Neupane YR, Pavon MV, Zharkova O, Pastorin G, Wang JW. Extracellular Vesicles in Cardiovascular Diseases: Alternative Biomarker Sources, Therapeutic Agents, and Drug Delivery Carriers. Int J Mol Sci 2019;20:E3272. [PMID: 31277271 DOI: 10.3390/ijms20133272] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 13.0] [Reference Citation Analysis]
13 Do AD, Kurniawati I, Hsieh CL, Wong TT, Lin YL, Sung SY. Application of Mesenchymal Stem Cells in Targeted Delivery to the Brain: Potential and Challenges of the Extracellular Vesicle-Based Approach for Brain Tumor Treatment. Int J Mol Sci 2021;22:11187. [PMID: 34681842 DOI: 10.3390/ijms222011187] [Reference Citation Analysis]
14 Chakravarti AR, Pacelli S, Paul A. Investigation of human adipose stem cell-derived nanoparticles as a biomimetic carrier for intracellular drug delivery. Nanoscale 2020;12:24273-84. [PMID: 33295935 DOI: 10.1039/d0nr06571d] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Ou YH, Liang J, Czarny B, Wacker MG, Yu V, Wang JW, Pastorin G. Extracellular Vesicle (EV) biohybrid systems for cancer therapy: Recent advances and future perspectives. Semin Cancer Biol 2021:S1044-579X(21)00029-8. [PMID: 33609664 DOI: 10.1016/j.semcancer.2021.02.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
16 Escudé Martinez de Castilla P, Tong L, Huang C, Sofias AM, Pastorin G, Chen X, Storm G, Schiffelers RM, Wang JW. Extracellular vesicles as a drug delivery system: A systematic review of preclinical studies. Adv Drug Deliv Rev 2021;175:113801. [PMID: 34015418 DOI: 10.1016/j.addr.2021.05.011] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
17 Alkaff SA, Radhakrishnan K, Nedumaran AM, Liao P, Czarny B. Nanocarriers for Stroke Therapy: Advances and Obstacles in Translating Animal Studies. Int J Nanomedicine 2020;15:445-64. [PMID: 32021190 DOI: 10.2147/IJN.S231853] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
18 Huang C, Neupane YR, Lim XC, Shekhani R, Czarny B, Wacker MG, Pastorin G, Wang JW. Extracellular vesicles in cardiovascular disease. Adv Clin Chem 2021;103:47-95. [PMID: 34229852 DOI: 10.1016/bs.acc.2020.08.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]